315 related articles for article (PubMed ID: 34801057)
21. The expression pattern of Von Hippel-Lindau tumor suppressor protein, MET proto-oncogene, and TFE3 transcription factor oncoprotein in renal cell carcinoma in Upper Egypt.
Nagi FM; Omar AA; Mostafa MG; Mohammed EA; Abd-Elwahed Hussein MR
Ultrastruct Pathol; 2011 Apr; 35(2):79-86. PubMed ID: 21299348
[TBL] [Abstract][Full Text] [Related]
22. Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family.
Olivero M; Valente G; Bardelli A; Longati P; Ferrero N; Cracco C; Terrone C; Rocca-Rossetti S; Comoglio PM; Di Renzo MF
Int J Cancer; 1999 Aug; 82(5):640-3. PubMed ID: 10417759
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study.
van Houwelingen KP; van Dijk BA; Hulsbergen-van de Kaa CA; Schouten LJ; Gorissen HJ; Schalken JA; van den Brandt PA; Oosterwijk E
BMC Cancer; 2005 Jun; 5():57. PubMed ID: 15932632
[TBL] [Abstract][Full Text] [Related]
24. Renal Cell Carcinoma with Clear Cell Papillary Features: Perspectives of a Differential Diagnosis.
Somorácz Á; Kuthi L; Micsik T; Jenei A; Hajdu A; Vrabély B; Rásó E; Sápi Z; Bajory Z; Kulka J; Iványi B
Pathol Oncol Res; 2020 Jul; 26(3):1767-1776. PubMed ID: 31656019
[TBL] [Abstract][Full Text] [Related]
25. Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.
Williamson SR; Gupta NS; Eble JN; Rogers CG; Michalowski S; Zhang S; Wang M; Grignon DJ; Cheng L
Am J Surg Pathol; 2015 Nov; 39(11):1502-10. PubMed ID: 26457355
[TBL] [Abstract][Full Text] [Related]
26. [Hereditary kidney cancers: The pathologist's view in 2020].
Verkarre V; Morini A; Denize T; Ferlicot S; Richard S
Ann Pathol; 2020 Apr; 40(2):148-167. PubMed ID: 32197858
[TBL] [Abstract][Full Text] [Related]
27. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma.
Morrissey C; Martinez A; Zatyka M; Agathanggelou A; Honorio S; Astuti D; Morgan NV; Moch H; Richards FM; Kishida T; Yao M; Schraml P; Latif F; Maher ER
Cancer Res; 2001 Oct; 61(19):7277-81. PubMed ID: 11585766
[TBL] [Abstract][Full Text] [Related]
28. Clinical and molecular characterization of Brazilian families with von Hippel-Lindau disease: a need for delineating genotype-phenotype correlation.
Gomy I; Molfetta GA; de Andrade Barreto E; Ferreira CA; Zanette DL; Casali-da-Rocha JC; Silva WA
Fam Cancer; 2010 Dec; 9(4):635-42. PubMed ID: 20567917
[TBL] [Abstract][Full Text] [Related]
29. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas.
Schmidt L; Duh FM; Chen F; Kishida T; Glenn G; Choyke P; Scherer SW; Zhuang Z; Lubensky I; Dean M; Allikmets R; Chidambaram A; Bergerheim UR; Feltis JT; Casadevall C; Zamarron A; Bernues M; Richard S; Lips CJ; Walther MM; Tsui LC; Geil L; Orcutt ML; Stackhouse T; Lipan J; Slife L; Brauch H; Decker J; Niehans G; Hughson MD; Moch H; Storkel S; Lerman MI; Linehan WM; Zbar B
Nat Genet; 1997 May; 16(1):68-73. PubMed ID: 9140397
[TBL] [Abstract][Full Text] [Related]
30. Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene.
Schmidt LS; Nickerson ML; Angeloni D; Glenn GM; Walther MM; Albert PS; Warren MB; Choyke PL; Torres-Cabala CA; Merino MJ; Brunet J; Bérez V; Borràs J; Sesia G; Middelton L; Phillips JL; Stolle C; Zbar B; Pautler SE; Linehan WM
J Urol; 2004 Oct; 172(4 Pt 1):1256-61. PubMed ID: 15371818
[TBL] [Abstract][Full Text] [Related]
31. Identification of copy number alterations and its association with pathological features in clear cell and papillary RCC.
Matsuda D; Khoo SK; Massie A; Iwamura M; Chen J; Petillo D; Wondergem B; Avallone M; Kloostra SJ; Tan MH; Koeman J; Zhang Z; Kahnoski RJ; ; Baba S; Teh BT
Cancer Lett; 2008 Dec; 272(2):260-7. PubMed ID: 18682315
[TBL] [Abstract][Full Text] [Related]
32. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
[TBL] [Abstract][Full Text] [Related]
33. Molecular Genetic Alterations in Renal Cell Carcinomas With Tubulocystic Pattern: Tubulocystic Renal Cell Carcinoma, Tubulocystic Renal Cell Carcinoma With Heterogenous Component and Familial Leiomyomatosis-associated Renal Cell Carcinoma. Clinicopathologic and Molecular Genetic Analysis of 15 Cases.
Ulamec M; Skenderi F; Zhou M; Krušlin B; Martínek P; Grossmann P; Peckova K; Alvarado-Cabrero I; Kalusova K; Kokoskova B; Rotterova P; Hora M; Daum O; Dubova M; Bauleth K; Slouka D; Sperga M; Davidson W; Rychly B; Perez Montiel D; Michal M; Hes O
Appl Immunohistochem Mol Morphol; 2016 Aug; 24(7):521-30. PubMed ID: 26447894
[TBL] [Abstract][Full Text] [Related]
34. Renal cell carcinoma with leiomyomatous stroma--further immunohistochemical and molecular genetic characteristics of unusual entity.
Peckova K; Grossmann P; Bulimbasic S; Sperga M; Perez Montiel D; Daum O; Rotterova P; Kokoskova B; Vesela P; Pivovarcikova K; Bauleth K; Branzovsky J; Dubova M; Hora M; Michal M; Hes O
Ann Diagn Pathol; 2014 Oct; 18(5):291-6. PubMed ID: 25175809
[TBL] [Abstract][Full Text] [Related]
35. Do Clear Cell Papillary Renal Cell Carcinomas Have Malignant Potential?
Diolombi ML; Cheng L; Argani P; Epstein JI
Am J Surg Pathol; 2015 Dec; 39(12):1621-34. PubMed ID: 26426379
[TBL] [Abstract][Full Text] [Related]
36. Clear cell renal cell carcinoma: a comparative study of histological and chromosomal characteristics between primary tumors and their corresponding metastases.
Dagher J; Kammerer-Jacquet SF; Dugay F; Beaumont M; Lespagnol A; Cornevin L; Verhoest G; Bensalah K; Rioux-Leclercq N; Belaud-Rotureau MA
Virchows Arch; 2017 Jul; 471(1):107-115. PubMed ID: 28488172
[TBL] [Abstract][Full Text] [Related]
37. Atypical Renal Cysts: A Morphologic, Immunohistochemical, and Molecular Study.
Matoso A; Chen YB; Rao V; Wang L; Cheng L; Epstein JI
Am J Surg Pathol; 2016 Feb; 40(2):202-11. PubMed ID: 26574846
[TBL] [Abstract][Full Text] [Related]
38. CAIX and pax-8 Commonly Immunoreactive in Endolymphatic Sac Tumors: A Clinicopathologic Study of 26 Cases with Differential Considerations for Metastatic Renal Cell Carcinoma in von Hippel-Lindau Patients.
Thompson LDR; Magliocca KR; Andreasen S; Kiss K; Rooper L; Stelow E; Wenig BM; Bishop JA
Head Neck Pathol; 2019 Sep; 13(3):355-363. PubMed ID: 30291511
[TBL] [Abstract][Full Text] [Related]
39. Exploring the hereditary background of renal cancer in Denmark.
Christensen MB; Wadt K; Jensen UB; Lautrup CK; Bojesen A; Krogh LN; Overeem Hansen TV; Gerdes AM
PLoS One; 2019; 14(4):e0215725. PubMed ID: 31034483
[TBL] [Abstract][Full Text] [Related]
40. Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features.
Adeniran AJ; Shuch B; Humphrey PA
Am J Surg Pathol; 2015 Dec; 39(12):e1-e18. PubMed ID: 26559379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
